Johnson & Johnson says nipocalimab approved in China - Reuters

Reuters | May 21, 2026, 5:49 a.m. | Original
Johnson & Johnson says nipocalimab approved in China Reuters
CEO Dimon says JPMorgan to hire more AI staff, fewer bankers, Bloomberg News reports - Reuters Samsung pay deal brings relief but exposes divisions in South Korean city - Reuters